Skip to content

Drug interactions

Indacaterol + Saquinavir

Severity: Moderate

Indacaterol and Saquinavir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Saquinavir inhibits CYP3A4 and P-glycoprotein and may increase indacaterol exposure, with greater beta-adrenergic effects. Saquinavir also prolongs QT and PR intervals, adding to arrhythmia risk.

What this interaction means in plain words

Indacaterol and Saquinavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4/P-gp clearance of indacaterol plus additive QT prolongation.

What to do

Obtain a baseline ECG and monitor heart rate, potassium and ECG during co-use. Avoid other QT-prolonging agents when possible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol and Saquinavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Indacaterol with Saquinavir?

MediHelp rates the interaction as moderate. Indacaterol and Saquinavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Saquinavir inhibits CYP3A4 and P-glycoprotein and may increase indacaterol exposure, with greater beta-adrenergic effects. Saquinavir also prolongs QT and PR intervals, adding to arrhythmia risk.

How serious is the interaction between Indacaterol and Saquinavir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor heart rate, potassium and ECG during co-use. Avoid other QT-prolonging agents when possible.

What other medicines interact with Indacaterol?

MediHelp also lists interactions of Indacaterol with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Indacaterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in